OVES Enterprise accelerates investments, allocating €3 million for R&D in 2025

Business Forum
OVES Enterprise, a Romanian software development company specializing in complex software solutions and AI innovations for the aerospace, defense, and cybersecurity industries, announces a €3 million budget for investments in 2025, supporting the company's accelerated growth with a focus on research and development.

A substantial portion of this amount will be allocated to enhancing Nemesis AI, an artificial intelligence platform playing a critical role in structuring, labeling, and preparing data from conflict zones, which are subsequently used to train and deploy AI models in complex systems such as autonomous drones and aircraft.

Nemesis AI has already garnered interest from some of the largest global defense companies seeking to integrate this platform to enhance their technological capabilities.

"Nemesis AI is an example of how innovation can transform strategic industries. Our platform plays a vital role in processing and analyzing complex data from critical areas, such as conflict zones, contributing to the advancement of autonomous technologies like drones and smart aircraft. However, we are far from reaching the full potential of this product, which is why we plan to invest heavily in 2025 to improve its functionalities and develop new modules tailored to government institutions and international organizations," said Mihai Filip, CEO of OVES Enterprise.

Plans to attract strategic funding

In addition to internal investments, OVES Enterprise is exploring external funding opportunities to sustain its accelerated development pace. The company is targeting collaborations with investment funds specializing in military and technological industries or private investors who understand the needs of this sector.

"Developing technologies that address global challenges requires significant budgets. While we allocate considerable resources, an external partner would enable us to accelerate development and bring revolutionary products to market. We already have seven products in various stages of development, and in 2025, we aim to transform these ideas into fully-fledged complete solutions with immediate applicability," emphasized Mihai Filip.

New commercial products

A new strategic direction for OVES Enterprise in 2025 involves focusing on AI-based commercial products. The company is developing solutions addressing global challenges, such as commercial flight safety and wildfire prevention.

"Our new commercial products demonstrate the versatility of our team and our ability to create technologies that directly impact people's lives. These solutions not only tackle urgent problems but also open new markets for OVES Enterprise, contributing to revenue diversification," added Mihai Filip.

At the same time, the company acknowledges the limitations of the local market in terms of innovation budgets. To maximize its global impact, products like Nemesis AI may benefit from intellectual property registration in larger markets, such as the United States.

"We are pro-Romania, but we must adapt to global realities. In countries like the US, financial resources and access to partnership networks are incomparable. This is the direction we consider necessary to turn our ideas into truly revolutionary products," added Mihai Filip.

OVES Enterprise expands global presence

For 2025, global expansion remains a priority, with OVES Enterprise planning to open new offices in strategic regions. Markets in the US and UK continue to be the main revenue sources, generating the largest share of the company's estimated turnover.

Simultaneously, the company will continue investing in attracting and training specialists in artificial intelligence, robotics, and aerospace engineering.

RECOMMENDED
RECOMMENDED FROM THE HOME PAGE
Electro-Alfa plans IPO on BVB
Finance

Electro-Alfa plans IPO on BVB

Electro-Alfa International, a Romanian electrical equipment manufacturer, has announced plans for an Initial Public Offering (IPO) on the Bucharest Stock Exchange (BVB).

Industry

Life sciences M&A surges 81% as big pharma hunts for growth, says EY

Global life sciences M&A activity increased by 81% in 2025 to $240 billion, driven by Big Pharma's large-scale deals, despite fewer overall transactions. The surge reflects companies prioritising innovations ready for launch as they face widening growth gaps.

Finance

Romania launches first 2026 Fidelis bond IPO on stock exchange

Romania's Ministry of Finance will conduct its first public offering of Fidelis government bonds for 2026 between January 16 and 23 on the Bucharest Stock Exchange. This marks the 32nd offering since the Fidelis program resumed in July 2020.

READ MORE
Business Forum  |  16 January, 2026 at 5:00 PM
Business Forum  |  16 January, 2026 at 4:13 PM